Please wait...
Rubicon Publications
Home >> Publish book chapter >> Advances in Drugs Research for Discovery, Development and Safety (Volume - 1)

Publish a Book Chapter in "Advances in Drugs Research for Discovery, Development and Safety (Volume - 1)"

Call for Book Chapters: Submissions Now Open


978-1-80433-859-9

Drugs Edited Book | Edited Book on Pharmaceutical Science


This edited book on drugs titled "Advances in Drugs Research for Discovery, Development and Safety" mainly focuses on various topics such as drug discovery pipelines, target identification, target validation etc., and the rest are given below in the Scope of the book. This pharmaceutical science edited book will be published with ISBN numbers after following a proper double blind peer reviewed process. All the chapters of this drugs edited book will be published in a proper style, so that reader can easily understand and learn.

Author can download this drugs edited book titled "Advances in Drugs Research for Discovery, Development and Safety" authorship responsibility and copyright form: Click Here

Indexed In


Indexed in Crossref Indexed in Dimensions Indexed in Bowker
ISBN978-1-80433-859-9

Invited Topics

  1. Drug Discovery and Development: A Modern End-to-End Overview
  2. Identifying and Validating Drug Targets Using Experimental and Computational Tools
  3. High-Throughput Screening and Hit Identification Strategies
  4. Lead Optimization and Structure–Activity Relationship Development
  5. Structure-Based Drug Design and Molecular Docking Applications
  6. QSAR Modeling and Predictive Toxicology in Early Discovery
  7. Artificial Intelligence and Machine Learning in Drug Discovery Pipelines
  8. Omics-Driven Target Discovery and Pathway Analysis
  9. Biomarkers in Drug Development: Selection, Validation, and Clinical Utility
  10. ADME Screening and Early Pharmacokinetic Risk Assessment
  11. Pharmacokinetics Fundamentals for Translational Dose Selection
  12. Pharmacodynamics and Exposure–Response Modeling in Development
  13. Physiologically Based PK Modeling for Prediction Across Populations
  14. Formulation Strategies for Poorly Soluble Drugs
  15. Advanced Drug Delivery Systems for Targeted Therapeutics
  16. Prodrug Design and Clinical Translation Considerations
  17. Biologics Development: Antibodies, Proteins, and Novel Modalities
  18. Biosimilars: Development Pathways and Regulatory Requirements
  19. Gene Therapy and Nucleic Acid Drugs: Principles and Safety Challenges
  20. Vaccine Development: Preclinical Evidence and Clinical Evaluation



For more topics: Click here
ISBN

ISBN: 978-1-80433-859-9

Book Scope

  • Drug Discovery Pipelines
  • Target Identification
  • Target Validation
  • Hit Screening Methods
  • Lead Optimization
  • Structure-Based Design
  • QSAR Modeling
  • AI in Drug Discovery
  • Omics-Driven Targets
  • Biomarker Discovery
  • ADME Screening
  • PK Studies
  • PD Modeling
  • Dose Selection
  • Formulation Design
  • Drug Delivery Systems
  • Prodrugs Development
  • Biologics Development
  • Biosimilars Pathways
  • Gene Therapy Basics
  • Vaccine Development
  • Preclinical Toxicology
  • Safety Pharmacology
  • Genotoxicity Testing
  • Carcinogenicity Studies
  • Reproductive Toxicology
  • Immunotoxicity
  • Drug–Drug Interactions
  • CYP Enzyme Studies
  • Transporter Studies
  • First-in-Human Trials
  • Phase I Design
  • Phase II Endpoints
  • Phase III Methods
  • Adaptive Trial Design
  • Real-World Evidence
  • Pharmacovigilance Systems
  • Signal Detection
  • Risk Management Plans
  • Benefit–Risk Assessment
  • Quality by Design
  • GMP Compliance
  • Analytical Validation
  • Stability Studies
  • Impurity Profiling
  • Counterfeit Detection
  • Regulatory Submissions
  • Ethics in Trials
  • Patient Safety Monitoring
  • Post-Marketing Studies


Author Guidelines

To download guidelines: Click here


Submit Chapter

To submit chapter: Click here

OR

Send your chapter on rubiconpublications@gmail.com



Deadline

31 Jan 2026